Electra Therapeutics (ETRA) vs REGENXBIO (RGNX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Electra Therapeutics is the larger company by market cap ($567.4 million vs $532.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ETRA | RGNX |
|---|---|---|
| Share price | $9.04 | $8.07 |
| Market cap | $567.41M | $532.73M |
| 1-day change | -1.09% | -0.25% |
| YTD return | — | -43.82% |
| 1-year return | — | -33.80% |
| 5-year return | — | -77.50% |
| EPS (TTM) | $-2.65 | $-3.78 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.50 | $16.19 |
| 52-week low | $8.63 | $5.46 |
| Distance from 52-week high | -41.68% | -50.15% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +192.19% |
| Average volume | 912.83K | 1.53M |
| Shares outstanding | 62.77M | 66.01M |
| Employees | 46 | 371 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Electra Therapeutics
ETRA stock →Electra Therapeutics, Inc. is a clinical-stage biotechnology company.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 46 employees
About REGENXBIO
RGNX stock →REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 371 employees
ETRA vs RGNX FAQ
Which is bigger, Electra Therapeutics or REGENXBIO?
Electra Therapeutics (ETRA) is larger, with a market capitalization of $567.41M compared with $532.73M for REGENXBIO (RGNX).
Are Electra Therapeutics and REGENXBIO in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.